Page last updated: 2024-09-03

omega-n-methylarginine and Carotid Artery Diseases

omega-n-methylarginine has been researched along with Carotid Artery Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bralley, JA; Chirinos, JA; Chirinos-Pacheco, J; Corrales-Medina, F; Cuba-Bustinza, C; David, R; Medina-Lezama, J; Muñoz-Atahualpa, E; Zea-Díaz, H1
Bennett, MR; Boyle, JJ; Weissberg, PL1

Other Studies

2 other study(ies) available for omega-n-methylarginine and Carotid Artery Diseases

ArticleYear
Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:6

    Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Blood Flow Velocity; Blood Pressure; Carotid Artery Diseases; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Predictive Value of Tests; Prognosis; Pulsatile Flow; Regression Analysis; Risk Factors

2008
Human macrophage-induced vascular smooth muscle cell apoptosis requires NO enhancement of Fas/Fas-L interactions.
    Arteriosclerosis, thrombosis, and vascular biology, 2002, Oct-01, Volume: 22, Issue:10

    Topics: Apoptosis; Autocrine Communication; Carotid Artery Diseases; Cells, Cultured; Enzyme Inhibitors; Fas Ligand Protein; fas Receptor; Golgi Apparatus; Humans; Ligands; Macrophages; Membrane Glycoproteins; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroprusside; omega-N-Methylarginine; Polyamines; Protein Transport; Up-Regulation

2002